Logo
x

Search

Subscribe Now

Everest Medicine

PharmaShots Weekly Snapshots (December 04 – December 08, 2023)

PharmaShots Weekly Snapshots (December 04 – December 08, 2023)

  • December 8, 2023
The NMPA Accepts Everest Medicine's IND Application for Zetomipzomib to Treat Immune Mediated Disorders

The NMPA Accepts Everest Medicine's IND Application for Zetomipzomib to Treat Immune Mediated Disorders

  • December 4, 2023
Everest Medicine’s Nefecon Receives NMPA Approval for the Treatment of Primary IgA Nephropathy

Everest Medicine’s Nefecon Receives NMPA Approval for the Treatment of Primary IgA Nephropathy

  • November 24, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.